Bridgewater Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Bridgewater Advisors's VKTX Position: Q3 2026 in Review
Bridgewater Advisors opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 13,169 shares worth $332K. The stake represents 0.02% of the portfolio and ranks #352 among its holdings.
444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Bridgewater Advisors held 13,169 shares of Viking Therapeutics worth $332K as of Q3 2026.
- Viking Therapeutics was a new Bridgewater Advisors position in Q3 2026.
- Viking Therapeutics made up 0.02% of Bridgewater Advisors's portfolio in Q3 2026, its #352 holding.
- 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Bridgewater Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.